Treatment outcomes of extensively drug-resistant tuberculosis in Europe: a retrospective cohort study.

Saved in:
Bibliographic Details
Title: Treatment outcomes of extensively drug-resistant tuberculosis in Europe: a retrospective cohort study.
Authors: Kherabi Y; Infectious and Tropical Diseases Department, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France.; Université Paris Cité, Inserm, IAME, Paris, France., Skouvig Pedersen O; Department of Respiratory Medicine and Allergy, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Lange C; Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany.; German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Borstel, Germany.; Respiratory Medicine and International Health, University of Lübeck, Lübeck, Germany.; Baylor College of Medicine and Texas Children Hospital, Global TB Program, Houston, TX, USA., Bénézit F; Infectious Disease and Intensive Care Unit, Pontchaillou University Hospital, Rennes, France., Chesov D; Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany.; German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Borstel, Germany.; Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova.; Chiril Draganiuc Pneumology Institute, Chisinau, Republic of Moldova., Codecasa LR; Regional TB Reference Centre, Instituto Villa Marelli, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Dudnyk A; Department of Tuberculosis, Clinical Immunology and Allergy, National Pirogov Memorial Medical University, Vinnytsia, Ukraine.; Institut d'Investigació Germans Trias i Pujol (IGTP), Barcelona, Spain., Kiria N; National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia., Konstantynovska O; Department of Infectious Diseases and Clinical Immunology, V.N. Karazin Kharkiv National University, Kharkiv, Ukraine.; 'Regional Phtisiopulmonological Center' of the Kharkiv Regional Council, Communal Non-commercial Enterprise, Kharkiv, Ukraine.; Department of Infectious Disease, Imperial College London, London, UK., Marigot-Outtandy D; Sanatorium, Centre Hospitalier de Bligny, Briis-sous-Forges, France., Panciu TC; Marius Nasta Institute of Pneumology Bucharest, Bucharest, Romania., Poignon C; Sorbonne-Université, INSERM, CNRS, Centre d'Immunologie et de Maladies Infectieuses, CIMI, Paris, France.; Assistance Publique Hôpitaux de Paris, Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié-Salpêtrière, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, Paris, France., Sasi S; Department of Microbiology and Molecular Diagnostics, Laboratory, North Estonia Medical Centre, Tallinn, Estonia., Schaub D; Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany.; German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Borstel, Germany.; Respiratory Medicine and International Health, University of Lübeck, Lübeck, Germany., Solodovnikova V; TBnet, Bad Oldesloe, Germany., Vasiliauskaitè L; Department of Physiology, Biochemistry, Microbiology and Laboratory Medicine, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.; Centre of Laboratory Medicine, Laboratory of Infectious Diseases and Tuberculosis, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania., Yeghiazaryan L; National Center of Pulmonology, Abovyan, Republic of Armenia., Günther G; Department of Pulmonary Medicine, Allergology and Clinical Immunology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Department of Medical Sciences, School of Medicine, University of Namibia, Windhoek, Namibia., Guglielmetti L; Department of Infectious, Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy.
Corporate Authors: TBnet/ESGMYC XDR-TB Study Group
Source: The Lancet regional health. Europe [Lancet Reg Health Eur] 2025 Jul 15; Vol. 56, pp. 101380. Date of Electronic Publication: 2025 Jul 15 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: [Oxford] Country of Publication: England NLM ID: 101777707 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-7762 (Electronic) Linking ISSN: 26667762 NLM ISO Abbreviation: Lancet Reg Health Eur Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2666-7762
DOI:10.1016/j.lanepe.2025.101380